CD8A and hepatocellular carcinoma: For example, low CD8+ TILs were associated with low pretreatment SMI or sarcopenia in patients with early‐stage pancreatic ductal adenocarcinoma [34], hepatocellular carcinoma [35], extrahepatic cholangiocarcinoma [36] or colorectal cancer [37].